Nigeria Centre for Disease Control
© Credits

Mpox

    Overview

    Mpox (previously known as monkeypox) is a viral disease caused by an orthopoxvirus called monkeypox virus. It spreads mainly through close contact with someone who has mpox, causing a painful rash, enlarged lymph nodes and fever. It can make people very sick and leave scars.

    The disease mainly spreads from person to person through close contact. This includes, but isn’t limited to, sexual contact. Transmission occurs through exposure to bodily fluids; lesions on the skin or on internal mucosal surfaces, such as in the mouth or throat; respiratory particles; and contaminated objects. 

    In areas where animals carry the virus, mpox is a zoonotic disease, meaning it can spread from animals to humans. It's found in tropical rainforests in central, east and west Africa, where small mammals such as squirrels, Gambian pouched rats, dormice, and various species of monkeys may be carriers.

    Since May 2022, mpox has spread globally, with cases reported from countries without previously documented mpox transmission. The spread in most countries today is from people and not animals.

    Symptoms

    Mpox typically causes a fever, a rash resembling pimples or blisters and swollen lymph nodes.   Symptoms usually appear within a week of exposure but can take anywhere from 1 to 21 days to develop.

    The illness often begins with a feverish phase lasting 1 to 3 days with symptoms including intense headache, swollen lymph nodes back pain, muscle aches and severe fatigue. The first stage is followed by the skin eruption stage, lasting from 2 to 4 weeks. Lesions evolve from macules (lesions with a flat base) to papules (raised firm painful lesions) to vesicles (filled with clear fluid) to pustules (filled with pus), followed by scabs or crusts.  They can leave scars. For some people, the first symptom of mpox is the rash.

    Some people with mpox become very sick and it can even be fatal in some cases. Children, pregnant people and people with weak immune systems, including people living with HIV that is not well controlled, are at higher risk for serious illness and death due to complications from mpox.

    Prevention and treatment

    Prevention and control of mpox rely on raising awareness in communities and educating health workers to prevent infection and stop transmission.

    Mpox vaccines also provide protection against infection and severe disease. WHO recommends the use of vaccines for those most at risk of exposure during outbreaks, including people who have had close contact with someone with mpox, and health workers. People who were vaccinated against smallpox in childhood may have some cross-protection against mpox. 

    To prevent spread, close contact with people who have mpox or with contaminated materials should be avoided. Masks, gloves and other personal protective equipment should be worn while taking care of the sick, whether in a health facility or at home. 

    Where animal-to-human transmission is possible, contact with sick or dead animals should be avoided, and all foods containing animal meat or parts must be properly cooked before consumption. 

    Care of patients with mpox should focus on managing symptoms to make people feel better, and to prevent medical complications. Potential treatments against mpox are being developed and tested.

    News

    All →

    Latest publications

    All →
    Smallpox and mpox 
(orthopoxviruses): WHO position paper, August 2024

    This position paper is concerned with vaccines and vaccination against mpox and smallpox. Since the publication of the 2014 meeting report on smallpox...

    WHO SEAR 17th Epidemiological Bulletin 2024

    This epidemiological bulletin aims to provide the situation of key infectious diseases in the WHO South-East Asia region to inform risk assessments and...

    WHO advisory committee on variola virus research: report of the twenty-fifth meeting, Geneva, Switzerland, 25-26 October 2023

    The World Health Organization (WHO) Advisory Committee on variola virus Research (ACVVR), held its twenty-fifth meeting on 25-26 October 2023. The recommendations...

    WHO SEAR 11th Epidemiological Bulletin 2024

    This epidemiological bulletin aims to provide the situation of key infectious diseases in the WHO South-East Asia region to inform risk assessments and...

    WHO documents

    All →
    Mpox Situation Report #38 Thumbnail

    This is the 38th situation report for the multi-country outbreak of mpox, which provides an update on the mpox epidemiological situation in Africa as of...

    A coordinated research roadmap Monkeypox virus-Immediate research next steps to contribute to control the outbreak-Thumb

    A scientific conference was held on August 29-30, 2024. It focused on aligning mpox research with outbreak response goals. This meeting was part of a comprehensive effort...

    This is the 37th situation report for the multi-country outbreak of mpox, which provides an update of the weekly mpox epidemiological situation in Africa,...

    This technical document provides a taxonomy for understanding the mpox outbreak that can be applied to online social media listening, as well as for offline...